Case Report on Patients with Steinert Disease Complicated by COVID-19
Autor: | Roberto Chalela, Karys Khilzi, Diego A Rodríguez-Chiaradía, Oswaldo Antonio Caguana, Flavio Zuccarino |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Lung business.industry Endocrinology Diabetes and Metabolism Mortality rate Respiratory disease Public Health Environmental and Occupational Health Hematology General Medicine Emergency department Disease 030204 cardiovascular system & hematology medicine.disease Pulmonary embolism 03 medical and health sciences Pneumonia 0302 clinical medicine medicine.anatomical_structure Internal medicine Concomitant medicine Pharmacology (medical) 030212 general & internal medicine Cardiology and Cardiovascular Medicine business |
Zdroj: | Vascular Health and Risk Management. 16:463-466 |
ISSN: | 1178-2048 |
DOI: | 10.2147/vhrm.s266659 |
Popis: | SARS-CoV-2 infection is predominantly a respiratory disease with a diverse clinical spectrum. Pulmonary thromboembolic complications during COVID-19 pneumonia may be associated with a high mortality rate and post-mortem findings confirm the presence of platelet-fibrin thrombi in arterial vessels of patients together with lung tissue alterations. We present a patient transferred to the emergency department due to a syncope with no other associated symptoms, who was diagnosed with an acute pulmonary embolism (PE) concomitant with SARS-CoV-2 infection without lung infiltrates. Presenting with a PE as the only manifestation of this infection, reinforces our conception of COVID-19 as a heterogeneous disease of which we still know very little. We believe that while the virus is still circulating in our environment, we need to consider ruling out COVID-19 in all thrombotic events, even if the patients have no other risk factors. |
Databáze: | OpenAIRE |
Externí odkaz: |